Overview

A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
French national multicentric phase III trial evaluating chemotherapy with Folfirinox or gemcitabine in locally advanced pancreatic carcinoma.
Phase:
Phase 3
Details
Lead Sponsor:
UNICANCER
Treatments:
Fluorouracil
Folic Acid
Gemcitabine
Irinotecan
Leucovorin
Levoleucovorin
Oxaliplatin